These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7902479)

  • 21. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
    Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
    Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of long-term beta-blockade therapy in patients with dilated cardiomyopathy--serial clinical and echocardiographic observations.
    Yokota Y; Nomura H; Kawai H; Fukuzaki H
    Jpn Circ J; 1992 Jan; 56(1):52-61. PubMed ID: 1538576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy.
    Currie PJ; Kelly MJ; McKenzie A; Harper RW; Lim YL; Federman J; Anderson ST; Pitt A
    J Am Coll Cardiol; 1984 Jan; 3(1):203-9. PubMed ID: 6140277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and haemodynamic effects of oral metoprolol therapy in dilated cardiomyopathy.
    Nair M; Sethi KK; Agrawal R; Arora R; Khalilullah M
    Indian Heart J; 1990; 42(6):411-4. PubMed ID: 2098312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diltiazem improves cardiac function and exercise capacity in patients with idiopathic dilated cardiomyopathy. Results of the Diltiazem in Dilated Cardiomyopathy Trial.
    Figulla HR; Gietzen F; Zeymer U; Raiber M; Hegselmann J; Soballa R; Hilgers R
    Circulation; 1996 Aug; 94(3):346-52. PubMed ID: 8759075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy].
    Sinagra G; Perkan A; Zecchin M; Di Lenarda A; Lardieri G; Rakar S; Secoli G; Pinamonti B; Camerini F
    G Ital Cardiol; 1995 Oct; 25(10):1255-63. PubMed ID: 8682221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
    N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.
    Sanderson JE; Chan SK; Yu CM; Yeung LY; Chan WM; Raymond K; Chan KW; Woo KS
    Heart; 1998 Jan; 79(1):86-92. PubMed ID: 9505927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy.
    Juillière Y; Barbier G; Feldmann L; Grentzinger A; Danchin N; Cherrier F
    Eur Heart J; 1997 Feb; 18(2):276-80. PubMed ID: 9043845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More favourable haemodynamic effects from metoprolol than from captopril in patients with dilated cardiomyopathy.
    Jansson K; Karlberg KE; Nylander E; Karlsson E; Nyquist O; Dahlström U
    Eur Heart J; 1997 Jul; 18(7):1115-21. PubMed ID: 9243145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of metoprolol on the beta-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy.
    Ishida S; Makino N; Masutomo K; Hata T; Yanaga T
    Am Heart J; 1993 May; 125(5 Pt 1):1311-5. PubMed ID: 8386904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term beta-blockade (metoprolol) therapy in patients with dilated cardiomyopathy.
    Yokota Y; Nomura H; Kawai H; Tsumura Y; Takeuchi Y; Kurozumi H; Takarada A; Fukuzaki H
    Jpn Circ J; 1991 Apr; 55(4):343-55. PubMed ID: 2046141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial.
    Fisher ML; Gottlieb SS; Plotnick GD; Greenberg NL; Patten RD; Bennett SK; Hamilton BP
    J Am Coll Cardiol; 1994 Mar; 23(4):943-50. PubMed ID: 8106700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reductions in muscle sympathetic nerve activity after long-term metoprolol for dilated cardiomyopathy: preliminary observations.
    Rahman MA; Hara K; Daly PA; Wigle ED; Floras JS
    Br Heart J; 1995 Oct; 74(4):431-6. PubMed ID: 7488460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIC trial: metoprolol in patients with mild to moderate heart failure: effects on ventricular function and cardiopulmonary exercise testing.
    Genth-Zotz S; Zotz RJ; Sigmund M; Hanrath P; Hartmann D; Böhm M; Waagstein F; Treese N; Meyer J; Darius H
    Eur J Heart Fail; 2000 Jun; 2(2):175-81. PubMed ID: 10856731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new method using pulmonary gas-exchange kinetics to evaluate efficacy of beta-blocking agents in patients with dilated cardiomyopathy.
    Taniguchi Y; Ueshima K; Chiba I; Segawa I; Kobayashi N; Saito M; Hiramori K
    Chest; 2003 Sep; 124(3):954-61. PubMed ID: 12970023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of race in the response to metoprolol in patients with congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
    Freudenberger R; Kalman J; Mannino M; Buchholz-Varley C; Ocampo O; Kukin M
    Am J Cardiol; 1997 Nov; 80(10):1372-4. PubMed ID: 9388121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.
    Peters DH; Benfield P
    Pharmacoeconomics; 1994 Oct; 6(4):370-400. PubMed ID: 10147474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment.
    Kakuchi H; Sasaki T; Ishida Y; Komamura K; Miyatake K
    Heart; 1999 Feb; 81(2):148-52. PubMed ID: 9922349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early changes in longitudinal performance predict future improvement in global left ventricular function during long term beta adrenergic blockade.
    Andersson B; Waagstein F; Caidahl K; Eurenius I; Täng MS; Wikh R
    Heart; 2000 Dec; 84(6):599-605. PubMed ID: 11083735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.